Fulzos 250mg (Fulvestrant PFS) 250mg/5ml

Fulzos 250mg is a prescription injectable used for hormone receptor-positive breast cancer treatment. This 250mg/5ml pre-filled syringe offers targeted therapy under medical supervision. Fulzos 250mg PFS provides a convenient option for managing advanced breast cancer symptoms.

Strength

250mg/5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Hetero Healtchare Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fulzos 250mg is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women. It works by blocking estrogen receptors, helping slow cancer progression. Fulzos 250mg is often prescribed after other hormonal therapies. The medication may also be used for advanced breast cancer in combination with other treatments.

Side Effects

Fulzos 250mg may cause mild to moderate injection site reactions, including pain or redness. Some users report fatigue, nausea, or hot flashes during treatment. Headaches and joint pain are also commonly reported effects. These effects vary by individual and should be discussed with a healthcare provider.

Precautions & Warnings

Fulzos 250mg should be handled with care to avoid accidental exposure. Keep the pre-filled syringe refrigerated between 2-8°C and protect from light. Do not freeze or shake the syringe. Always follow healthcare provider instructions for administration and disposal.

Avoid Interactions

Fulzos 250mg may interact with other hormonal therapies or medications affecting estrogen levels. Caution is advised when combining with blood thinners or CYP3A4 inhibitors. Alcohol use may increase certain side effects like nausea. Always inform your doctor about all medications and supplements being taken.

References

Frequently Asked Questions

Fulzos 250mg is used to treat hormone receptor-positive metastatic breast cancer in postmenopausal women.

Fulzos 250mg is given as an injection by a healthcare professional, typically once monthly.

Common side effects include injection site reactions, fatigue, nausea, and hot flashes.

Fulzos 250mg is a prescription medication and should only be purchased with a valid prescription.

Fulzos 250mg should be stored refrigerated between 2-8°C and protected from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.